269
human parvovirus B19 structural proteins. J. Virol. 65: 2702–
2706.
Brown CS, Jensen T, Meloen R, Puijk W, Sugamura K, Sato H &
Spaan WJH (1992) Localization of an immunodominant domain
on baculovirus-produced parvovirus B19 capsids: correlation to
a major surface region on the native virus particle. J. Virol. 66:
6989–6996.
Brown CS (1994) Human parvovirus B19. Expression and applica-
tions of its structural proteins. Ph.D. Thesis. Leiden University.
Brown CS, Welling-Wester S, Feijlbrief M, Van Lent JWM & Spaan
WJH (1994) Chimeric parvovirus B19 capsids for the presenta-
tion of foreign epitopes. Virology. 198: 477–480.
Casal JI, Cortés E, Lopez de Turiso JA & Vela C (1992) Production
of porcine and canine parvovirus-like particles using recombi-
nant baculovirus. In: “Baculovirus and recombinant protein pro-
duction processes” JM Vlak, EJ Schlaeger & AR Bernard (eds)
pp. 76–92. Editiones Roche. Basel. Switzerland.
Christensen JT, Storgaard T, Bloch B, Alexandersen S & Aasted B
(1993) Expression of aleutian mink disease parvovirus proteins
in a baculovirus vector system. J. Virol. 67: 229–238.
Christensen J, Alexandersen S, Bloch B, Aasted B & Uttenthal A
(1994) Production of mink enteritis parvovirus empty capsids by
expresion in a baculovirus vector system: a recombinant vaccine
for mink enteritis virus. J. Gen. Virol. 75: 149–155.
Cortés E, SanMartin C, Langeveld J, Meloen R, Dalsgaard K, Vela
C & Casal JI (1993) Topographical analysis of canine parvovirus
virions and recombinant VP2 capsids. J. Gen. Virol. 74: 2005–
2010.
Cotmore SF & Tattersall P (1987) The autonomously replicating
parvoviruses of vertebrates. Adv. Virus Res. 33: 91-174.
Gray JJ, Cohen BJ & Desselberger U (1993) Detection of human
parvovirus B19-specific IgM and IgG antibodies using a recom-
binant viral VP1 antigen expresse in insect cells and stimation of
time of infection by testing for antibody avidity. J. Virol. Methods
44: 11–24.
Hurtado A, Rueda P, Nowicky J, Sarraseca J & Casal JI (1996)
Identification of domains in canine parvovirus VP2 essential for
the assembly of virus-like particles. J. Virol. In press.
Joo HS, Donaldson-Wood CR & Johnson RHA (1976) A stan-
dardized hemagglutination-inhibition test for porcine parvovirus.
Aust. Vet. J. 52: 422–424.
Kajigaya S, Fuji H, Field A, Anderson S, Rosenfeld S, Anderson LJ,
Shimada T & Young NS (1991) Self-assembled B19 parvovirus
capsids, produced in a baculovirus system are antigenically and
immunogenically similar to native virions. Proc. Natl. Acad. Sci.
U SA 88: 4646–4650.
Kool M, Voncken JW, Van Lier FLJ, Tramper J & Vlak JM (1991)
Detection and analysis of Autographa californica nuclear polyhe-
drosis virus mutants with defective interfering properties. Virol-
ogy 183:739–746.
Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese M & Young
NS (1989) Immune response to B19 parvovirus and an antibody
defect in persistent viral infection. J. Clin. Invest. 84:1114–1123.
Langeveld J, Casal JI, Vela C, Dalsgaard K, Smale SH, Puijk WC &
Meloen R (1993) B cell epitopes of canine parvovirus: distribu-
tion on the primary structure and exposure on the viral surface. J.
Virol. 67: 765–772.
Langeveld J, Kamstrup S, Uttenthal A, Strandbygaard B, Vela C,
Dalsgaard K, Beekam N, Meloen R & Casal JI (1995) Full pro-
tection in mink against mink enteritis virus with new generation
canine parvovirus vaccines based on synthetic peptides or recom-
binant protein. Vaccine. 13: 1033–1037.
Lopez de Turiso JA, Cortés E, Ranz A, Garcia J, Sanz A, Vela C
and Casal JI (1991) Fine mapping of canine parvovirus B cell
epitopes. J. Gen. Virol. 72: 2445–2456.
Lopez de Turismo JA, Cortés E, Martinez C, Ruiz de Ybañez R,
Simarro I, Vela C & Casal JI (1992) Recombinant vaccine for
canine parvovirus in dogs. J. Virol. 66: 2748–2753.
Luckow VA & Summers MD (1988) Trends in the development of
baculovirus expression vectors. Bio/Technology 6: 47–55.
Luckow V (1991) Cloning and expression of heterologous genes
in insect cells with baculovirus vectors. In: Recombinant DNA
technology and applications, A Procop, RK Bajpai & CS Ho
(eds) pp. 97–153. McGraw-Hill, Inc. New York.
Martinez C, Dalsgaard K, Lopez de Turismo JA, Cortés E, Vela C &
Casal JI (1992) Construction of porcine parvovirus empty capsids
with high immunogenic activity. Vaccine 10: 684–690.
Matsuura Y, Possee RD, Overton HA & Bishop DHL (1987) Bac-
ulovirus expression vectors: The requirements for high level
expression of proteins, including glycoproteins. J. Gen. Virol.
68: 1233-1250.
Miyamura K, Kajigaya S, Momoeda M, Smith-Gill SJ & Young NS
(1994) Parvovirus particles as platforms for protein presentation.
Proc. Natl. Acad. Sci. USA 91: 8507–8511.
Rosenfeld SJ, Yoshimoto K, Kajigaya S, Anderson S, Young NS,
Field A, Warrener P, Bansal G & Collet MS (1992) Unique region
of the minor capsid protein of human parvovirus B19 is exposed
on the virion surface. J. Clin. Invest. 89: 2023–2029.
Ruffing M, Zentgraf H & Kleinschmidt JA (1992) Assembly of
viruslike particles by recombinant structural proteins of adeno-
associated virus type 2 in insect cells. J. Virol. 66: 6922–6930.
Saikawa T, Anderson S, Momoeda M, Kajigaya S & Young NS
(1993) Neutralizing linear epitopes of B19 parvovirus cluster
in the VP1 unique and VP1-VP2 junction regions. J. Virol. 67:
3004–3009.
Saliki JT, Mizak B, Flore HP, Gettig RR, Burand JP, Carmichael LE,
Wood HA & Parrish CR (1992) Canine parvovirus empty capsids
produced by expression in a baculovirus vector: use in analysis
of viral properties and immunization of dogs. J. Gen. Virol. 61:
33–4l.
Salimans MMM, van Bussel MJAWM, Brown CS & Spaan WJM
(1992) Recombinant parvovirus B19 capsids as a new substrate
for detection of B19 specific IgG and IgM antibodies by an
enzyme-linked immunosorbent assay. J. Virol. Methods 39: 247–
258.
Sato H, Hirata J, Kuroda N, Shiraki Y, Maeda Y & Okochi K (1991)
Identification and mapping of neutralizing epitopes of human
parvovirus B19 by using human antibodies. J. Virol. 66: 106–
114.
Schwartz TF, Roggendorf M & Deinhardt F (1988) Human Par-
vovirus B19: ELISA and immunoblot assays. J. Virol. Methods
20: 155–168.
Sedlik C, Sarraseca J, Rueda P, Leclerc C & Casal JI (1995) Immuno-
genicity of poliovirus B and T cell epitopes presented by hybrid
porcine parvovirus particles. J. Gen. Virol. 76: 2361–2368.
in human serum. Bio/Technology 5: 1077–1080.
Tsao J, Chapman MS, Agbandje M, Keller W, Smith K, Wu H,
Luo M, Smith TJ, Rossmann MG, Compans RW & Parrish CR
(1991) The three dimensional structure of canine parvovirus and
its functional implications. Science 251: 1456–1464.
Tullis G, Burger L & Pintel DJ (1991) MVM VP2 is both required
and sufficient for the production of infectious virus. Abstracts 4th
Parvovirus Workshop. Elsinore. Denmark.
Sisk WP & Berman ML (1987) Expression of human parvovirus B19
structural protein in E. coli and detection of antiviral antibodies